Industry Sponsorship of Open Access Articles

"Authors listing industry sponsorship are more than twice as likely to pay open access fees to make their work freely accessible. This bias could lead to preferential reading of pro-industry results....Pro-industry bias is not new to medical publishing....Hybrid journals are not the only journals at risk for biased dissemination of research results. BioMed Central, a commercial company that specializes in the publication of full open access journals, lists many of the world’s top pharmaceutical companies as institutional members. If you are a researcher at Pfizer, Novartis, Sanofi-Aventis, or Bayer Schering Pharma, your company has already pre-paid Biomed Central to cover your future article processing charges...."